ERCC4 and COFS syndrome: In humans, ERCC1 mutations at residues 158 and 231, yielding a premature Q158X termination mutation, and a F231L mutation in the XPF‐interacting domain have been reported to cause Cockayne and COFS syndromes (Gregg et al., 2011; Jaspers et al., 2007).